type here...

CATEGORIES

Mental Health

LATEST

1...424344...52Page 43 of 52

TRENDING

EDITORS CHOICE

Inside the Tactical Tug of War Over the Controversial Alzheimer’s Drug

Medika Life -
This article was published orginally in Fortune and is authored by Arthur Allen and republished with permission from KHN (@khnews). The drug industry, patient advocates,...

Combating Loneliness Is Everyone’s Job

Pat Farrell PhD -
Loneliness, especially at holiday times, is part of the urban landscape, and it’s something that each of us needs to combat. The battle isn’t...

Groundbreaking Study Reveals Single LSD Dose Offers Instant and Sustained Anxiety Relief

Michael Hunter, MD -
After yielding promising results in a clinical trial, an LSD formulation aimed at treating generalized anxiety disorder has been awarded Breakthrough Therapy status by the U.S. Food and Drug Administration.

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston -
The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories